Literature DB >> 1183474

The effect of toxic and therapeutic doses of tricyclic antidepressant drugs on intracardiac conduction.

J Vohra, G Burrows, D Hunt, G Sloman.   

Abstract

Intracardiac conduction studies using His bundle electrography (HBE) were performed in 14 patients admitted to hospital following an overdosage of one of the tricyclic antidepressant drugs and in another 12 patients before and during administration of therapeutic doses of nortriptylline. Amongst the former group, 7 of 8 patients showed impaired distal intracardiac conduction (H-V interval) following overdosages of nortriptyline, imipramine or amitriptyline but none of the 6 patients with doxepin overdosage. The prolonged H-V interval had returned to normal at a repeat study 7 days later. In the therapeutic dose study, 5 of 12 patients showed an increase in the H-V interval by more than 10 msec during treatment with nortriptyline. Four of these 5 patients had plasma nortriptyline levels of over 200 ng/ml. Tricyclic antidepressant drugs show a quinidine-like effect in toxic, and in some patients, in therapeutic doses. This finding may having a bearing on the treatment of cardiac arrhythmias in patients following overdosage with these drugs and may provide a clue to the reported increase in the incidence of sudden deaths in 'cardiac patients' following therapeutic doses of such agents.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1183474

Source DB:  PubMed          Journal:  Eur J Cardiol        ISSN: 0301-4711


  24 in total

Review 1.  Adverse effects of antidepressants in the elderly.

Authors:  L Nolan; K O'Malley
Journal:  Drugs Aging       Date:  1992 Sep-Oct       Impact factor: 3.923

2.  Effects of antidepressants on the intraventricular conduction and the incidence of arrhythmias induced by programmed ventricular stimulation in the dog heart after myocardial infarction.

Authors:  M Nishimoto; H Hashimoto; T Ozaki; S Nagashima; M Nakashima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

3.  Cardiovascular (ECG and systolic time intervals) and anticholinergic effects of repeated doses of femoxetine--a comparison with amitriptyline and placebo in healthy men.

Authors:  S J Warrington; P Turner; B K Skrumsager
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

4.  An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.

Authors:  Joachim Wernicke; Alberto Lledó; Joel Raskin; Daniel K Kajdasz; Fujun Wang
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 5.  Doxepin up-to-date: a review of its pharmacological properties and therapeutic efficacy with particular reference to depression.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-03       Impact factor: 9.546

Review 6.  Poisoning due to tricyclic antidepressant overdosage. Clinical presentation and treatment.

Authors:  P Crome
Journal:  Med Toxicol       Date:  1986 Jul-Aug

Review 7.  Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

8.  Tricyclic antidepressant poisoning. Management of arrhythmias.

Authors:  P R Pentel; N L Benowitz
Journal:  Med Toxicol       Date:  1986 Mar-Apr

9.  The effect of tricyclic antidepressant drugs on the heart.

Authors:  P Dumovic; G D Burrows; J Vohra; B Davies; B A Scoggins
Journal:  Arch Toxicol       Date:  1976-08-18       Impact factor: 5.153

10.  Mianserin: cardiovascular effects in elderly patients.

Authors:  M Møller; P Thayssen; P Kragh-Sørensen; O L Pedersen; C B Kristensen; M Bjerre; S Benjaminsen; L F Gram
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.